Tolvaptan therapy to treat severe hyponatremia in pediatric nephrotic syndrome
ConclusionTolvaptan was very efficient in this case of hyponatremia associated with steroid-resistant NS. Tolvaptan should be considered in the management of therapy-resistant hyponatremia in patients with NS.
Source: Pediatric Nephrology - Category: Urology & Nephrology Source Type: research
More News: Calcium | Furosemide | Girls | Nephrotic Syndrome | Norvasc | Pediatrics | Prograf | Sodium | Tacrolimus | Urology & Nephrology